O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+9.47%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.34B
AUM Growth
+$6.34B
(-0.66%)
Cap. Flow
-$66.5M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
40.11%
Holding
139
New
17
Increased
27
Reduced
20
Closed
14
Top Buys
| 1 |
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
|
$182M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$104M |
| 3 |
uniQure
QURE
|
$70.2M |
| 4 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$67.5M |
| 5 |
Natera
NTRA
|
$59.2M |
Top Sells
| 1 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$272M |
| 2 |
Guardant Health
GH
|
$118M |
| 3 |
Viatris
VTRS
|
$66.4M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$64M |
| 5 |
Humana
HUM
|
$55.9M |
Sector Composition
| 1 | Healthcare | 97.38% |
| 2 | Financials | 1.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Abbott
ABT
$231B
| $78.9M | 1.22% | 938,000 +322,600 | +52% | +$27.1M |
|
27
eHealth
EHTH
$118M
| $78.3M | 1.21% | 909,814 -271,400 | -23% | -$23.4M |
|
|
ATNX
28
DELISTED
Athenex, Inc. Common Stock
ATNX
| $76M | 1.18% | 3,840,130 +3,410,130 | +793% | +$67.5M |
|
|
THOR
29
DELISTED
Synthorx, Inc. Common Stock
THOR
| $71.8M | 1.11% | 5,316,355 | – | – |
|
|
30
uniQure
QURE
$896M
| $70.2M | 1.09% | +897,800 | New | +$70.2M |
|
31
MeiraGTx Holdings
MGTX
$587M
| $69.5M | 1.08% | 2,586,951 +126,700 | +5% | +$3.41M |
|
32
Regeneron Pharmaceuticals
REGN
$61.5B
| $67.5M | 1.05% | 215,800 +1,000 | +0.5% | +$313K |
|
33
Agilent Technologies
A
$35.7B
| $66.7M | 1.03% | 893,200 +94,500 | +12% | +$7.06M |
|
|
BOLD
34
DELISTED
Audentes Therapeutics, Inc
BOLD
| $64.9M | 1% | 1,713,069 -101,931 | -6% | -$3.86M |
|
35
Bristol-Myers Squibb
BMY
$96B
| $61M | 0.94% | 1,345,200 +150,200 | +13% | +$6.81M |
|
36
Arvinas
ARVN
$568M
| $58.9M | 0.91% | 2,678,810 | – | – |
|
|
PRNB
37
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $53.3M | 0.83% | 1,605,713 -1,000,000 | -38% | -$33.2M |
|
38
Illumina
ILMN
$15.8B
| $51.6M | 0.8% | 140,200 -87,100 | -38% | -$32.1M |
|
39
Crinetics Pharmaceuticals
CRNX
$2.92B
| $51M | 0.79% | 2,039,282 +125,000 | +7% | +$3.12M |
|
40
Adicet Bio
ACET
$59.9M
| $49.3M | 0.76% | 4,830,387 | – | – |
|
|
MYOK
41
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $47.9M | 0.74% | 955,300 +48,700 | +5% | +$2.44M |
|
42
Apellis Pharmaceuticals
APLS
$3.48B
| $46.2M | 0.72% | 1,823,700 +61,400 | +3% | +$1.56M |
|
|
VRAY
43
DELISTED
ViewRay, Inc.
VRAY
| $45.4M | 0.7% | 5,149,019 | – | – |
|
44
argenx
ARGX
$43.6B
| $43.9M | 0.68% | 310,400 -50,900 | -14% | -$7.21M |
|
45
Zai Lab
ZLAB
$3.68B
| $40.8M | 0.63% | 1,169,000 -232,318 | -17% | -$8.1M |
|
46
NextCure
NXTC
$13.5M
| $40.6M | 0.63% | +2,711,013 | New | +$40.6M |
|
47
Cigna
CI
$80.3B
| $39.8M | 0.62% | 252,600 | – | – |
|
48
DexCom
DXCM
$29.5B
| $39.4M | 0.61% | 262,900 +124,200 | +90% | +$18.6M |
|
49
Tandem Diabetes Care
TNDM
$845M
| $36.8M | 0.57% | 570,790 -60,510 | -10% | -$3.9M |
|
50
Prothena Corp
PRTA
$441M
| $32.4M | 0.5% | 3,065,278 +630,000 | +26% | +$6.66M |
|